LYEL 8-K 2026-09-10

Lyell Immunopharma, Inc. (LYEL) 8-K dated 2026-09-10 — accession 0001193125-26-387890. This URL is the filing, not the LYEL hub.

Lyell Immunopharma, Inc. (LYEL) is a biotechnology company listed on US.

Lyell Immunopharma, Inc. filed a 8-K on 2026-09-10. Accession 0001193125-26-387890.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LYEL revenue for 2025-12-31 was $36.0K. Net income was -$274.4M. Revenue was down 41.0% from 2024-12-31 to 2025-12-31. LYEL currently screens at market cap $143.5M.

Not investment advice. The LYEL SEC hub lists recent forms. The stock page is the research view.